首页> 外国专利> 1-methylfolate treatment for psychiatric or neurological disorders.

1-methylfolate treatment for psychiatric or neurological disorders.

机译:1-甲基叶酸治疗精神病或神经系统疾病。

摘要

1-methylfolate treatment for psychiatric or neurological disorders. Disclosed herein are methods of treating neuropsychiatric disorders or ameliorating the symptoms associated therewith with administering a medicinal food, such as 1-methylfolate, to a subject having the disorder. Neuropsychiatric treatment may be an autism spectrum disorder or attention deficit disorder with or without hyperactivity (add / adhd). 1-methylfolate may be administered as an adjunct to other effective therapeutic agents for treating the disorder. the subject may preferably be a child and may also have a single nucleotide polymorphism in the mthfr gene associated with reduced expression of the mthfr enzyme. Also provided is a method for increasing de novo synthesis of neurotransmitters in vivo by transporting a methyl-donor compound across an individual's brain blood barrier.
机译:1-甲基叶酸治疗精神病或神经系统疾病。本文公开了治疗神经精神疾病或减轻与之相关的症状的方法,该方法是对患有该疾病的受试者施用药物食品,例如1-甲基叶酸。神经精神病学治疗可以是自闭症谱系障碍或注意力缺陷障碍,伴或不伴过度活跃(添加/多动症)。可以将1-甲基叶酸作为其他有效的治疗疾病的辅助药物进行治疗。所述受试者可以优选是儿童,并且还可以在mthfr基因中具有与mthfr酶表达降低相关的单核苷酸多态性。还提供了通过跨个体的脑血屏障转运甲基供体化合物来增加体内神经递质从头合成的方法。

著录项

  • 公开/公告号BR112012033695A2

    专利类型

  • 公开/公告日2016-11-01

    原文格式PDF

  • 申请/专利权人 ROBERT L. QUILLIN;

    申请/专利号BR20121133695

  • 发明设计人 ROBERT L. QUILLIN;

    申请日2011-06-09

  • 分类号A61K51;A61M36/14;

  • 国家 BR

  • 入库时间 2022-08-21 14:27:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号